Lv4
714 积分 2022-02-28 加入
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial
11天前
已完结
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host Disease
22天前
已完结
Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis
23天前
已完结
BCMA/CD19 dual-targeting CAR T cell therapy in older patients with newly diagnosed multiple myeloma: a phase I study
24天前
已关闭
A novel nanobody-based TCR-like CAR-T therapy targeting PRAME for the treatment of acute myeloid leukemia
24天前
已完结
A novel nanobody-based TCR-like CAR-T therapy targeting PRAME for the treatment of acute myeloid leukemia
24天前
已完结
Utility of Thrombopoietin Receptor Agonists for Prolonged Thrombocytopenia After Chimeric Antigen Receptor T-cell Therapy
25天前
已完结
Lymphocyte dynamics after CAR ‐T therapy for non‐Hodgkin lymphoma
25天前
已完结
Multicenter Real‐World Analysis of Glofitamab in Relapsed/Refractory Primary CNS Lymphoma: Clinical Activity, CNS Penetration, and ctDNA Dynamics
25天前
已完结
皖公网安备34019202002308
